Is HTSUF stock a buy right now?

Meyka AI grades HTSUF B+ with a BUY suggestion. For an oversold bounce, consider partial buying near **$29.00** with stops under **$28.00**. This is not personalized advice; run your own checks.

What is the short-term price target for HTSUF stock?

Short-term model and technicals point to a quarterly target around **$34.61**. Use staged exits and confirm momentum above the 200-day at **$29.41** before adding size.

What risks should traders watch for HTSUF stock?

Primary risks include low liquidity (avg vol **90.00**), FX exposure from Japan operations, and misses at the earnings date **2026-04-08**. Tight stops and position sizing are essential.

How does valuation look for HTSUF stock?

Valuation is moderate: P/E **16.76**, P/B **1.17**, dividend yield **2.44%**, and strong cash per share **1,562.03**. These metrics support a cautious bounce trade with defined risk controls.

US Stocks

HTSUF Hisamitsu Pharmaceutical (PNK) $29.00 16 Feb 2026: Oversold bounce setup

ByHuzaifa Zahoor February 16, 2026February 16, 2026

On market hours 16 Feb 2026 HTSUF stock trades at $29.00, presenting a classic oversold bounce setup for short-term traders. Volume is light at 100.00 shares versus an average of 90.00, keeping price moves contained. The snapshot shows a one-year range of $24.56–$32.30, P/E 16.76, and EPS 1.73, all relevant to a bounce-from-support approach. We outline technical triggers, valuation checks, and a targeted price path for traders considering a measured entry.